Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Adverum biotechnologies, inc. symbols : GSK save search
Adverum Files Definitive Proxy Materials and Mails Letter to Stockholders Detailing Strength of Team and Acceleration Toward Commercialization of ADVM-022
Published: 2021-04-15 (Crawled : 19:00) - globenewswire.com
GSK | $39.565 0.75% 170K
|
Health Technology
|
| O: 4.23%
H: 1.59%
C: 0.08%
PASG | $1.15 -4.17% 26K
|
Health Technology
|
| O: 0.06%
H: 4.09%
C: 3.37%
GRTS | $0.7676 3.21% 140K
|
Health Technology
|
| O: 1.52%
H: 5.29%
C: 1.72%
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: 3.26%
H: 0.0%
C: -3.48%
ALGS | $0.7931 12K
|
Health Technology
|
| O: 2.13%
H: 3.4%
C: 1.18%
ADVM | $11.175 0.22% 2.1K
|
Health Technology
|
| O: 1.42%
H: 2.69%
C: 1.08%
commercialization
Gainers vs Losers
| 83% | 17% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0835 131.94% 160M
|
CHRO | $1.73 41.22% 46K
|
n/a
ZCMD | $1.98 36.55% 27M
|
Commercial Services
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.304 25.57% 47M
|
Manufacturing
WISA 4 | $7.19 22.07% 18M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
LIFW | News | $0.99 19.26% 800K
|
Administrative and Support and ...
Your saved searches
Save your searches and get alerts when important news are released.